Overview

Repeat Dosing of Psilocybin in Migraine Headache

Status:
Recruiting

Trial end date:
2023-07-15

Target enrollment:

Participant gender:

Summary

In seeking to understand the capacity for psilocybin to reduce migraine headache burden, this study will investigate single and repeated dosing of psilocybin up to two doses. In seeking to identify an underlying mechanism in psilocybin's effects, neuroinflammatory markers for migraine headache will be measured.

Phase:

Phase 1

Details

Lead Sponsor:

Yale University

Collaborator:

Wallace Research Foundation

Treatments:

Psilocybin